Glow Peptide Stack 60 mg

About Glow Peptide Stack

Glow is three research peptides freeze-dried together at a fixed 10 : 1 : 1 ratio by weight, so the powder is five sixths GHK-Cu.²¹ GHK, a tripeptide found naturally in human plasma, binds copper, and most authors attribute its effects to that binding.² BPC-157 is a synthetic 15-amino-acid fragment of a gastric juice protein.³¹⁴ TB-500 is a synthetic, acetylated piece of thymosin beta-4 (amino acids 17 to 23), which FDA says is not the same substance as thymosin beta-4.⁴

The Glow peptide for sale here is one 60 mg vial for laboratory research.²¹ Read What is Glow Peptide Stack? for the full evidence review, or compare single ingredients among our research peptides.

Research highlights

• No study of the blend. PubMed searches on October 24, 2026 found no study testing Glow or any GHK-Cu, BPC-157 and TB-500 mix; the only papers naming all three were reviews.¹⁰⁹
• Two ingredients together, in rats. In a 2026 randomized study of 32 rats after Achilles tendon repair, TB-500 alone significantly raised maximum load to failure versus controls; combining it with BPC-157 added no benefit over either peptide alone.¹¹
• GHK-Cu gel, in people. In a 1994 randomized, placebo-controlled trial in people with diabetes, a GHK-Cu gel on foot ulcers reached 98.5% median closure versus 60.8% with vehicle gel.¹² Controlled human trials of injected GHK-Cu are absent, a 2026 review notes.¹³
• BPC-157 in people. A 2026 systematic review found three small studies with 30 participants in total and rated the evidence very low certainty.¹⁴
• TB-500 in people. FDA found no published study in which TB-500 was given to humans.⁴
• Animal safety signals. In 28-day studies reviewed by FDA, rats and dogs given BPC-157 into muscle showed altered clotting times and liver-related signals.³

Regulatory status

Glow is not an approved drug: FDA states that neither BPC-157 nor TB-500 is a component of an FDA-approved drug.³⁴ All three (GHK-Cu for injectable routes) were once in FDA's compounding Category 2, for substances that may present significant safety risks; the nominators withdrew them, and FDA still lists safety concerns for each.¹⁵ For its July 2026 advisory committee meeting, FDA proposed keeping BPC-157 and TB-500 off the 503A Bulks List of substances compounding pharmacies may use.¹⁶ The committee voted 8 to 6 to recommend them, a nonbinding vote, and no proposed rule had appeared in the Federal Register by October 24, 2026.¹⁷¹⁸ FDA says a meeting before the end of February 2027 will discuss GHK-Cu for the same list.²² WADA's 2026 Prohibited List covers BPC-157 (S0) and TB-500 (S2).¹⁹ Health Canada names all three among unauthorized injectable peptides it has seized and says "research use only" labels do not make them legal.²⁰

Handling and storage

Glow ships as one freeze-dried powder, so adding diluent reconstitutes all 60 mg at once.²¹ Researchers who buy glow peptide therefore work with a fixed ratio: any solution made from the vial carries 10 mg of GHK-Cu and 1 mg of TB-500 per 1 mg of BPC-157.²¹ Lab steps are in How to reconstitute a peptide vial, and the reconstitution calculator works out concentration from vial size and diluent volume.

Supplies listed with this vial, each sold separately: Bacteriostatic Water, the 3mL Syringe, Luer-Lok Tip, the 18G 1-Inch Needle, Insulin Syringes and Alcohol Swabs. The glow peptide price is for the vial alone.

A 2026 review reports that chemical analyses of direct-to-consumer peptides found severe manufacturing variability, including significant deviations from stated doses.¹³ Before you buy glow peptide online, check which tests the seller's lot certificate reports; see our lab results page. For larger orders, see wholesale.